A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in ...

Individuals who received either the AS01 shingles or RSV vaccine had a significantly lower risk of developing dementia.

Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...

Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

Recent studies have shown convincingly that vaccines against shingles (Herpes zoster) reduce the risk of dementia.

More information: Trans amplifying mRNA vaccine expressing consensus spike elicits broad neutralization of SARS CoV 2 variants, npj Vaccines (2025). DOI: 10.1038/s41541-025-01166-1 Journal ...

A study published this week in NPJ Vaccines found that a new type of mRNA vaccine could more easily adapt to protect against constantly evolving viruses such as COVID-19 and the bird flu.